In a previous analysis of TCGA LUAD RNA-seq data, we identified a marked reduction in expression of Parkinson’s susceptibility gene Leucine Rich Repeat Kinase 2 (LRRK2), in tumors versus matched normal lung3. This evidence concerns the gene LRRK2 and Parkinson disease.